Form 4: Dolby Director Sells 3,300 Shares Under 10b5-1 Plan

Dolby Laboratories Director Tony Prophet sold 3,300 shares of Class A Common Stock for $67.85 per share under a pre-arranged trading plan.

Summary

• Tony A. Prophet, a Director at Dolby Laboratories, Inc. (DLB), reported a sale of company stock.
• On November 25, 2025, Prophet disposed of 3,300 shares of Class A Common Stock.
• The shares were sold at a price of $67.85 per share.
• This transaction was executed pursuant to a Rule 10b5-1(c) trading plan, indicating it was pre-arranged.
• Following the transaction, Prophet beneficially owns 9,107 shares of Dolby Laboratories Class A Common Stock.
• The remaining 9,107 shares include 3,140 shares underlying restricted stock units (RSUs) that are subject to vesting.

Sentiment

Score: 5

Explanation: The transaction is a pre-planned sale under a Rule 10b5-1 plan, which typically indicates a scheduled liquidity event rather than a reaction to immediate company performance or outlook. While it's a reduction in insider ownership, the pre-scheduled nature mitigates negative sentiment.

Negatives

• A director selling shares, even under a 10b5-1 plan, could be perceived negatively by some investors as it reduces their direct stake in the company.

Future Outlook

NA

Industry Context

This is an insider transaction report, which is specific to the individual and company, not directly tied to broader industry trends unless it's part of a wider pattern of insider selling across the sector.

Stakeholder Impact

• Shareholders: May view the director's sale, even if pre-planned, as a slight negative signal regarding the director's personal conviction in the stock's immediate upside, though the 10b5-1 plan context lessens this impact.

Key Dates

Recommendation

The filing reports a routine, pre-scheduled sale of shares by a director under a 10b5-1 plan. This type of transaction is typically for personal financial planning and does not inherently signal a change in the company's fundamental outlook or performance. Therefore, it does not warrant a change in investment recommendation based solely on this filing. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Dolby Laboratories, DLB, Tony Prophet, Insider Sale, Form 4, Stock Transaction, Director, 10b5-1 Plan, Equity Sale